Revo Capital invests into developing East-European markets. Traction is required and B2B is preferred, but B2C is also ok.
They often look for a board seat. Their home market is in Turkey.
They consider themselves active helpers of their companies, especially in expanding beyond the home market. Founders of the fund have C-level background in the largest Turkish telecom.
They do VC tickets of €100k-500k, and growth tickets €200k-5M. They invest only in software with an emphasis on B2B and deep tech. Traction and sales are required, preference for over €500k ARR.
Preferred contact point is contact@mmgp.fi.
Presto Ventures is a Czech family office. They prefer B2B companies, but can also invest in B2C with good unit economics.
Family office of Skoda transportation company’s ex-owner. Heavy machinery is a special expertise area. Fund preference is for not too capital-intensive companies.
GrayBella Capital is a pan-European venture capital fund investing in healthcare and complex technology fast growth companies. They invest €2-7M in trenches and welcome other investors on board.
Their goal is to help companies scale internationally while keeping core operations locally in their primary market.
They have a preference for B2B. Their especial focus is on bioinformatics, genomics and other areas where health meets IT. Clinical trials are out of their scope.
Doing sustainability and impact investing: mobility, food and agriculture, energy (renewable, efficiency, storage), water, waste etc. Looking for indications of repeat demand.
Looking for defensible market positions. Technology is not necessary, if the position of the company is otherwise strategically defensible.
Investing globally with a focus on Europe. Also investing actively in Africa and Asia.
Focus on B2B across all their funds.
Prefer to lead or co-invest. Prefer to take a board seat.
Sparkmind.vc is the first Nordic venture capital company focused on the learning sector. They invest in teams transforming early childhood, K12, higher, secondary and vocational education as well as corporate and lifelong learning. Their geographical home field is Europe, especially North Europe, but they also selectively do investments outside the region.
They often join the boards of their portfolio companies.
Impact fund. Focuses on continental Nordics: Finland, Sweden, Norway, Denmark, with some emphasis also on Baltics. Prefers co-investing outside Sweden, but has also led rounds outside their home market.
Invests €0.5-1M on early stage companies. They exceptionally invest up to €2M initial tickets on later stage companies. Looking for a 5-10x return.
Open family office: network of family offices and angels. They do financial investments and prefer co-investing alongside existing investors.
They invest in solutions that customers like and have demand for. Solution doesn’t need to be technological, but it can be if lead investor has done technological due diligence.
Also offer loans for companies with any business types, including B2C.
They’ve invested €41M in four years.
Innovestor offers co-investing (syndicate forming) as a service. They also do solo investments.
Prefer B2B, but open to any business types. Drug development is not currently interesting for them, but digital health and medical technology is.
Funding applications can be filled at https://innovestorgroup.com/growth-companies/#applyfunding.
Karma Ventures invest into early-stage deep tech software in Baltics, Nordics, and in especially strong cases also elsewhere in Europe.
They’re looking for companies with technological advantage. Doesn’t have to be IPR, but something valuable and very hard to imitate. They look for companies with traction, first clients validating the demand, but in exceptional cases pre-revenue can also be considered.
In terms of sectors, life sciences are not their focus, but deep tech B2B health software can be interesting.
They prefer to lead, co-lead or invest solo.